If they say there has been a case, Ukoss will askformoredetails, though patients remain anonymous, so that they can analyse what happened in that particular case.
Thus, it seems sensible for regulators to ask firms formoredetails on their practices, or compel additional disclosures, when we are possibly in times of irrational exuberance.